Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 3/20 | 0.33 |
| ▸ | LDHA | P00338 | 2/20 | 0.32 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.31 |
| ▸ | DRD4 | P21917 | 2/20 | 0.31 |
| ▸ | TTR | P02766 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | KMO | O15229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346115 | 0.90 | CTSS (0.36) | CTSKCTSSLDHAUSP30DRD4 | |
| SCHEMBL31345970 | 0.80 | TTR (0.32) | TTRESR1ESR2 | |
| SCHEMBL31346087 | 0.80 | EZH2 (0.36) | CTSKCTSSLDHAUSP30DRD4 | |
| SCHEMBL31346014 | 0.78 | CTSS (0.47) | CTSKCTSS | |
| SCHEMBL31346003 | 0.76 | CTSS (0.42) | CTSKCTSS | |
| SCHEMBL31346020 | 0.74 | LDHA (0.49) | LDHATTRDRD2 | |
| SCHEMBL31346168 | 0.72 | — | — | |
| SCHEMBL28931690 | 0.71 | CTSK (0.46) | CTSKCTSSUSP30DRD4HTR1A | |
| SCHEMBL31346074 | 0.71 | DPP4 (0.30) | TTR | |
| SCHEMBL22463539 | 0.71 | CTSK (0.45) | CTSKCTSSUSP30DRD4HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |